(Q45234395)

11 December 2017

title

Significance of epidermal growth factor receptor expression in breast cancer (English)

1 reference

11 December 2017

author name string

Tanja Badovinac-Crnjevic

1

1 reference

11 December 2017

Jasminka Jakic-Razumovic

2

1 reference

11 December 2017

Paula Podolski

3

1 reference

11 December 2017

Stjepko Pleština

4

1 reference

11 December 2017

Božena Sarčević

5

1 reference

11 December 2017

Radenka Munjas

6

1 reference

11 December 2017

Damir Vrbanec

7

1 reference

11 December 2017

publication date

23 November 2010

1 reference

11 December 2017

1 reference

11 December 2017

volume

28 Suppl 1

1 reference

11 December 2017

page(s)

S121-8

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-010-9738-2

11 December 2017

exact match

0 references

cites work

Prognostic and predictive factors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Expression of epidermal growth factor receptor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Expression of c-erbB3 protein in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

c-erbB-4 protein expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Evaluating HER2 amplification and overexpression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9738-2

10.1007/S12032-010-9738-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1040117001

0 references

1 reference